Alexandria Real Estate Equities
ARE
#2146
Rank
S$11.95 B
Marketcap
S$68.58
Share price
0.30%
Change (1 day)
-27.66%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Net assets

Net assets on the balance sheet as of March 2026 : S$25.05 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company has S$25.05 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alexandria Real Estate Equities - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$S$24.59 B-19.22%
2024-12-31$S$30.44 B1.9%
2023-12-31$S$29.87 B-1.75%
2022-12-31$S$30.40 B18.18%
2021-12-31$S$25.73 B44.68%
2020-12-31$S$17.78 B29.76%
2019-12-31$S$13.70 B27.08%
2018-12-31$S$10.78 B24.38%
2017-12-31$S$8.67 B11.32%
2016-12-31$S$7.78 B28.25%
2015-12-31$S$6.07 B17.58%
2014-12-31$S$5.16 B2.47%
2013-12-31$S$5.04 B17.68%
2012-12-31$S$4.28 B-3.64%
2011-12-31$S$4.44 B15.57%
2010-12-31$S$3.84 B13.88%
2009-12-31$S$3.37 B35.66%
2008-12-31$S$2.48 B15.06%
2007-12-31$S$2.16 B0.15%
2006-12-31$S$2.16 B52.69%
2005-12-31$S$1.41 B39.8%
2004-12-31$S$1.01 B17.48%
2003-12-31$S$0.86 B2.21%
2002-12-31$S$0.84 B36.9%
2001-12-31$S$0.61 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
S$116.96 B 366.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$40.36 B 61.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.88 B-52.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$30.31 B 21.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.46 B-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$26.00 B 3.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.39 B-94.45%๐Ÿ‡บ๐Ÿ‡ธ USA